6533b858fe1ef96bd12b58de
RESEARCH PRODUCT
Survival of European children and young adults with cancer diagnosed 1995-2002
Gemma GattaGiulia ZigonRiccardo CapocacciaJan Willem CoeberghEmmanuel DesandesPeter KaatschGuido PastoreRafael Peris-bonetW. OberaignerM. HacklE. Van EyckenMartine VerstrekenJ. HolubL. JurickovaH. H. StormG. EngholmT. HakulinenA. BelotG. Hã©delinM. VeltenI. TronE. Le GallG. LaunoyA. V. GuizardJ. FaivreA. M. BouvierP. M. CarliM. Maynadiã©A. DanzonA. BuemiB. TretarreB. LacourE. DesandesM. ColonnaF. Moliniã©S. BaraC. SchvartzO. GanryP. GrosclaudeH. BrennerP. KaatschH. ZieglerL. TryggvadottirH. ComberF. BerrinoC. AllemaniP. BailiR. CiampichiniL. CiccolalloG. GattaA. MicheliM. SantS. SoweG. ZigonG. TagliabueP. ContieroF. Bellã¹A. GiacominS. FerrettiD. Serraino L. Dal MasoM. De DottoriA. De PaoliL. ZanierM. VercelliM. A. OrengoC. CasellaA. QuagliaF. PannelliM. FedericoI. RashidC. CirilliM. FuscoA. TrainaV. De LisiF. BozzaniC. MagnaniG. PastoreR. TuminoM. G. La RosaE. SpataA. SigonaL. MangoneF. FalciniF. FocaS. GiorgettiG. SenatoreA. IannelliM. BudroniR. ZanettiS. PatriarcaS. RossoS. PifferS. FranchiniE. PaciE. CrocettiF. La RosaF. StracciT. CassettiP. ZambonS. GuzzinatiM. CaldoraR. CapocacciaE. CarraniR. De AngelisS. FrancisciE. GrandeR. InghelmannH. LenzL. MartinaP. RoazziM. SantaquilaniA. SimonettiA. TavillaA. VerdecchiaM. DalmasF. LangmarkF. BrayT. B. JohannesenJ. RachtanS. Gã³åºdåºU. SiudowskaR. Mè©zykM. Bielska-lasotaM. ZwierkoP. S. PinheiroM. P. -. Z. Primic-å½akeljA. MateosI. IzarzugazaA. Torrella-ramosOscar ZurriagaR. Marcos-grageraM. L. VilardellA. IzquierdoC. Martinez-garciaM. J. Sã¡nchezC. NavarroM. D. ChirlaqueR. Peris-bonetE. ArdanazC. MorenoJ. GalceranÃ. . KlintM. Talbã¤ckG. JundtM. UselH. FrickS. M. EssA. BordoniJ. C. LuthiI. KonzelmannN. ProbstJ. M. LutzP. PuryO. VisserR. OtterM. SchaapveldJ. W. W. CoeberghM. L. Janssen-heijnenLouis Van Der HeijdenD. C. GreenbergM. P. ColemanLaura WoodsT. MoranD. FormanN. CooperM. RocheJ. VerneH. Mã¸llerD. MeechanJ. PooleG. LawrenceC. StillerA. GavinR. J. BlackD. H. BrewsterJ. A. StewardCharles A. Stillersubject
MaleCancer ResearchPediatricsMESH : Child PreschoolAdolescentsMESH: Epidemiologic Methods[ SDV.CAN ] Life Sciences [q-bio]/Cancer0302 clinical medicineMESH : ChildNeoplasmsMESH: ChildEpidemiologyMESH: NeoplasmsMESH : Female030212 general & internal medicineYoung adultChildChildrenChildren & young adults; Cancer survivalMESH : InfantPopulation-based cancer registriesChildren & young adultsMESH: Infant3. Good healthEuropeEastern europeanOncologyMESH: Young AdultChild Preschool030220 oncology & carcinogenesisMESH : Rare DiseasesRare tumoursFemaleMESH: Rare Diseasesmedicine.medical_specialtyAdolescentMESH : MaleMESH : EuropeMESH : Young AdultSocio-culturale[SDV.CAN]Life Sciences [q-bio]/CancerMESH : Epidemiologic MethodsYoung Adult03 medical and health sciencesRare DiseasesSDG 3 - Good Health and Well-beingMESH : AdolescentmedicineHumansPreschoolAdolescents; Cancer survival; Children; Europe; Population-based cancer registries; Rare tumours; Young adults; Adolescent; Child; Child Preschool; Epidemiologic Methods; Europe; Female; Humans; Infant; Male; Neoplasms; Rare Diseases; Young Adult; Oncology; Cancer ResearchSurvival analysisMESH: AdolescentMESH: Humansbusiness.industryMESH: Child PreschoolMESH : HumansInfantCancermedicine.diseaseMESH : NeoplasmsCancer survivalMESH: MaleCancer registryEl NiñoRelative riskMESH: EuropeEpidemiologic MethodsbusinessMESH: FemaleYoung adultsdescription
This study analyses survival in 40,392 children (age 0-14 years) and 30,187 adolescents/young adults (age 15-24 years) diagnosed with cancer between 1995 and 2002. The cases were from 83 European population-based cancer registries in 23 countries participating in EUROCARE-4. Five-year survival in countries and in regional groupings of countries was compared for all cancers combined and for major cancers. Survival for 15 rare cancers in children was also analysed. Five-year survival for all cancers combined was 81% in children and 87% in adolescents/young adults. Between-country survival differences narrowed for both children and adolescents/young adults. Relative risk of death reduced significantly, by 8% in children and by 13% in adolescents/young adults, from 1995-1999 to 2000-2002. Survival improved significantly over time for acute lymphoid leukaemia and primitive neuroectodermal tumours in children and for non-Hodgkin lymphoma in adolescents/young adults. Cancer survival in patients <25 years is poorly documented in Eastern European countries. Complete cancer registration should be a priority for these countries as an essential part of a policy for effective cancer control in Europe. (C) 2008 Elsevier Ltd. All rights reserved.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2009-04-01 |